After the past two bitterly contested presidential elections, both winners immediately spoke of reconciliation. “Now it is time for America to bind the wounds of division,” Donald Trump said ...
Day One Biopharmaceuticals reported a successful third quarter in 2024, driven by strong demand for its cancer therapy OJEMDA, which achieved $20.1 million in net revenue—a 145% increase from ...